EP3565553

INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    29.12.2017
  • :
    26.4.2023
  • :
    17890478.5
  • :
    28.12.2037
  • :
    INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER

29.12.2017
26.4.2023
  • :
    Santen Pharmaceutical Co., Ltd.
  • :
    9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, JP
  • :
    KUNDU, Aishwarya
  • :
    Emeryville California 94608, US
  • :
    ESCUDERO, Cecile
  • :
    Emeryville California 94608, US
  • :
    MUDUMBA, Sreenivasu
  • :
    Emeryville California 94608, US
  • :
    201762443599 P
  • :
    6.1.2017
  • :
    US
  • :
    JP2017047408
  • :
    29.12.2017
  • :
    A61K 31/436, A61K 9/08, A61K 47/10, A61K 47/18, A61K 47/20, A61K 47/22, A61K 47/24, A61K 47/26, A61K 47/34, A61K 47/36, A61P 35/00, A61K 45/06